Clemondo Group (CLEM) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
26 Feb, 2026Executive summary
Net sales increased by 11% year-over-year to 77.8 MSEK in Q4 2025, with all market areas contributing to growth.
EBITDA for the quarter was 6.0 MSEK (7.7% margin), down from 6.5 MSEK (9.2%) last year, reflecting strategic investments for future competitiveness.
EBIT was 2.4 MSEK (3.0% margin), and net income after tax was 1.7 MSEK, both lower than Q4 2024.
Full-year sales rose 11% to 291.2 MSEK, with EBITDA at 23.4 MSEK.
Peter Andersson assumed the CEO role on January 1, 2026.
Financial highlights
Gross margin improved to 40.4% from 39.1% year-over-year in Q4.
EBITDA margin for Q4 was 7.7% (down from 9.2%), and EBIT margin was 3.0% (down from 4.4%).
Earnings per share for Q4 were 0.12 SEK (0.18 SEK last year); full-year EPS was 0.40 SEK (0.45 SEK last year).
Cash flow from operations before working capital changes was 4.9 MSEK in Q4.
Soliditet (equity ratio) at quarter-end was 55.4% (62.4% last year).
Outlook and guidance
Continued focus on selective customer acquisition and strengthening competitiveness.
Management expects growth opportunities, especially in underutilized production capacity and new contracts.
Cautions that growth may not be linear due to timing of new business and ongoing investment costs.
Latest events from Clemondo Group
- Q3 2025 saw 13% sales growth and strong segment performance, but lower margins due to investments.CLEM
Q3 202511 Nov 2025 - Net sales rose 9% year-over-year, with strong growth in Medical Care and Industrial segments.CLEM
Q2 202520 Aug 2025 - Q3 2024 saw stable earnings, strong equity, and growth in Hygien and Industri amid a weak market.CLEM
Q3 202413 Jun 2025 - Sales declined but gross margin and financial position improved, with growth in Hygiene and Industry.CLEM
Q2 202413 Jun 2025 - Q1 2025 saw 12% sales growth, margin expansion, and Medical Care emerge as a key growth driver.CLEM
Q1 20256 Jun 2025 - Hygiene and Industry growth offset Vehicle weakness, with strong equity and new contracts for 2025.CLEM
Q4 20245 Jun 2025